Recent News

• 09.15.2025 - Labcorp Completes Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses
• 09.15.2025 - Labcorp Completes Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses
• 09.09.2025 - Morgan Stanley 23rd Annual Global Healthcare Conference
• 09.09.2025 - Morgan Stanley 23rd Annual Global Healthcare Conference
• 08.27.2025 - Labcorp to Speak at the Morgan Stanley 23rd Annual Global Healthcare Conference
• 08.27.2025 - Labcorp to Speak at the Morgan Stanley 23rd Annual Global Healthcare Conference
• 08.18.2025 - Labcorp Launches First FDA-Cleared Blood Test for Alzheimer's Disease
• 08.18.2025 - Labcorp Launches First FDA-Cleared Blood Test for Alzheimer's Disease
• 07.30.2025 - Labcorp Introduces Test Finder, a First-of-Its-Kind Generative AI Tool to Simplify Lab Test Search
• 07.30.2025 - Labcorp Introduces Test Finder, a First-of-Its-Kind Generative AI Tool to Simplify Lab Test Search

Recent Filings

• 08.28.2025 - EX-99.1 EX-99.1
• 08.28.2025 - 8-K Current report
• 08.15.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.13.2025 - 144 Report of proposed sale of securities
• 08.13.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.11.2025 - 144 Report of proposed sale of securities
• 08.01.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.01.2025 - 4 Statement of changes in beneficial ownership of securities
• 07.31.2025 - 4 Statement of changes in beneficial ownership of securities
• 07.30.2025 - 144 Report of proposed sale of securities